News | April 29, 2025
Indegene posts Q4 FY25 consolidated PAT at Rs. 117.6 Cr
The company has posted net profit of Rs. 406.7 crores for the Financial Year ended March 31, 2025
The company has posted net profit of Rs. 406.7 crores for the Financial Year ended March 31, 2025
The company has reported total income of Rs. 628.4 crores during the period ended March 31, 2025
Syngene reported revenue growth of 11% year-on-year, and 8% sequentially crossing the Rs. 1,000 Cr in a quarter threshold for the first time
For the financial year ended March 31, 2025, Thyrocare has reported total income of Rs.702.18 crores
The company delivered revenues of Rs. 5,554 crore, representing 10% growth in FY25
Revenue up 11% to Rs 5,768 crore as compared to Rs 5,197 crore
Total Income during Q3 FY25 stood at Rs. 527.37 crore as compared to Rs. 528.77 crore in Q3 FY24
During the quarter, US formulations revenue decreased by 2.3% YoY to Rs. 3,671 crore.
EBITDA rose to Rs. 14.8 crore, marking a 16.5% y-o-y increase, while net profit surged to Rs. 6.4 crore
The group reported Q3FY25 operating revenue of Rs 3,821 crore, driven by sustained double-digit growth of 14 per cent in biosimilars
Subscribe To Our Newsletter & Stay Updated
